Figure 2.

The antimicrobial activity of recombinant β-defensin 22 was determined with CFU assays. Triplicate assays were performed and the viabilities of three strains that represent G⁻, G⁺ and fungi pathogens are shown. The data were also analysed using one-way ANOVA and Duncan's multiple range test at the 5% level of significance (P<0.05) in Table 1. The bars indicate standard deviation. CFU, colony-forming units; G⁻, Gram-negative; G⁺, Gram-positive.